Department of Health and Human Services news from FierceBiotech
NewsFeds ok Iomai Phase II adjuvant patch study
Health and Human Services is giving Iomai the green light to do a mid-stage dose ranging study of its adjuvant patch for bird flu vaccine. HHS provided a $128 million contract backing Iomai's effort... Read more...
SPOTLIGHT: GAO questions antidotes for pandemic
The GAO says that a pandemic vaccine can offer little help during the crucial initial stages of an outbreak. The Department of Health and Human Services has estimated that it would take 20 to 23... Read more...
ALSO NOTED: AstraZeneca completes cancer study enrollment; Smallpox vaccine success triggers milestone; and much more...
> Here's a good estimate of how much it costs when a drug goes into free-fall: $440 million. That's how much Johnson & Johnson is writing off on Natrecor, a heart failure treatment that went... Read more...
Sanofi launches trial of revolutionary flu vaccine
Sanofi-Aventis has launched a mid-stage study of a new seasonal flu vaccine that hopes to advance a completely new method to make vaccines. The vaccine is made from cell cultures as opposed to the... Read more...
Report: FDA lax in clinical trial oversight
A new report has found that the FDA does little to protect the safety of patients who participate in clinical trials. Daniel R. Levinson, inspector general of the Department of Health and Human... Read more...
Press Release: HHS Unveils Two New Efforts to Advance Pandemic Flue PreparednessPress Release: HHS Unveils Two New Efforts to Advance Pandemic Flue Preparedness ... Read more...Press Release: Iomai Awarded Government ContractPress Release: Iomai Awarded Government Contract ... Read more...Press Release: GSK Awarded $63 Million HHS Contract for Pandemic Vaccine Research and DevelopmentPress Release: GSK Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development ... Read more...Press Release: BMS Announces Agreement In Principle to Settle Federal InvestigationPress Release: BMS Announces Agreement In Principle to Settle Federal Investigation ... Read more...Press Release: HHS Cancels VaxGen's Anthrax Vaccine ContractPress Release: HHS Cancels VaxGen's Anthrax Vaccine Contract ... Read more... | Press ReleasesPRESS RELEASE: HHS Remains Committed to Procurement of BioThrax Under Current Contract U.S. Department of Health and Human Services Remains Committed to Procurement of BioThrax Under Current Contract ROCKVILLE, Md. -- Nov. 19, 2007--Emergent BioSolutions Inc. (NYSE:EBS) announced Read more >> Statement by Mike Leavitt Secretary of HHS on the United States-China Meetings Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety WASHINGTON, Sept. 14 -- The following is a statement by Mike Read more >> |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
